Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Blood (2018) 131 (12): 1275–1291.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals